• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

statins

New cardiovascular risk equations could dramatically reduce statin and antihypertensive prescribing

cardiovascular disease, JAMA, PREVENT study, risk prediction, statins, 29 July 2024/in Cardiovascular Disease, E-News /by panglobal

A study published in JAMA estimates that adopting new cardiovascular disease risk prediction equations could make nearly 16 million fewer US adults eligible for preventive medications, potentially leading to over 100,000 additional occurrences of myocardial infarction or stroke over 10 years.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/statins.jpg 1068 1600 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-29 17:05:012024-07-25 14:29:55New cardiovascular risk equations could dramatically reduce statin and antihypertensive prescribing
dementia

Early-onset dementia: New study reveals higher incidence rates

Alzheimer’s disease, dementia, incidence, neurology, Research, 26 July 2024/in dementia, E-News, Neurology /by panglobal

A groundbreaking study from Finnish researchers uncovers alarming trends in early-onset dementia among working-age adults, with Alzheimer’s disease cases nearly doubling over the past decade.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/early_onset_dementia.jpg 1414 2121 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-26 08:00:102024-07-25 14:44:31Early-onset dementia: New study reveals higher incidence rates
BiVACOR Total Artificial HeartBiVACOR

BiVACOR Total Artificial Heart: First-in-human implantation marks new era in cardiac care

Artificial Heart, BiVACOR, bridge-to-transplant, Texas Heart Institute, 25 July 2024/in Cardiology, E-News, Editors' Picks, MedTech /by panglobal

A groundbreaking titanium artificial heart with a single moving part has been successfully implanted in a patient with end-stage heart failure, potentially revolutionising treatment options for those awaiting transplantation.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/BiVACOR-Total-Artificial-Heart.jpg 1055 2000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-25 13:50:362024-07-25 13:50:36BiVACOR Total Artificial Heart: First-in-human implantation marks new era in cardiac care
reelinTsai Lab/ MIT Picower Institute

New study sheds light on cellular vulnerabilities and resilience in Alzheimer’s disease

Alzheimer’s, brain, Genetics, Nature, Reelin, 24 July 2024/in dementia, E-News, Genetics, Neurology /by panglobal

A groundbreaking MIT study published in Nature offers new insights into the cellular mechanisms underlying Alzheimer’s disease, revealing potential targets for interventions to maintain cognitive function.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/reelin.jpg 549 700 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-24 17:05:592024-07-19 13:00:56New study sheds light on cellular vulnerabilities and resilience in Alzheimer’s disease
HumanIC

European project aims to improve hospital design with human-centred climate approach

climate change, Europe, healthcare-associated infections, hospital design, 22 July 2024/in E-News, Featured Articles, Hospital Design /by panglobal

The HumanIC project, funded by the EU’s Horizon Europe programme, seeks to create a new generation of scientists and engineers who will redefine hospital environments through innovative indoor climate design.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/HumanIC_logo.jpg 700 679 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-22 08:02:212024-07-19 13:11:33European project aims to improve hospital design with human-centred climate approach
3. Human stem cell-based embryo model – Blastoids. Blue marks all nuclei, the green label marks cells of the inner cell mass, and the pink label is a readout of a ribosomal protein.Irene Zorzan and Teresa Rayon, Babraham Institute

New Code of Practice for stem cell-based embryo models addresses ethical concerns

Code of Practice, embryo models, ethics, Research, stem cell, 22 July 2024/in E-News, Genetics /by panglobal

Scientists in the UK have developed the first code of practice for research using stem cell-based embryo models, providing ethical guidelines and governance for this rapidly advancing field.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/blastoid.png 1448 1448 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-22 08:00:352024-07-16 14:35:03New Code of Practice for stem cell-based embryo models addresses ethical concerns
Jeffrey Chamberlain and Hichem TasfaoutChamberlain Lab

New gene therapy breakthrough offers hope for Duchenne muscular dystrophy patients

Duchenne muscular dystrophy, Genetics, Nature, treatment, 19 July 2024/in Congenital Diseases, E-News, Genetics /by panglobal

A groundbreaking gene therapy for Duchenne muscular dystrophy (DMD) has demonstrated significant potential in not only arresting muscle decline but also possibly repairing damaged muscle tissue. This novel treatment, developed by researchers at UW Medicine, utilises a series of protein packets delivered via viral vectors to replace the defective DMD gene within affected muscles.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/Jeffrey-Chamberlain-left-and-Hichem-Tasfaout.jpg 426 640 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-19 13:29:132024-07-19 13:29:13New gene therapy breakthrough offers hope for Duchenne muscular dystrophy patients
hearing loss

Genome editing restores hearing in mice with progressive hearing loss

CRISPR/Cas9, gene, hearing loss, 19 July 2024/in E-News, Genetics /by panglobal

Research from Mass Eye and Ear demonstrates successful use of CRISPR/Cas9 to target and disrupt a genetic mutation causing hearing loss, offering hope for future treatments in humans.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/hearing_loss.jpg 974 1263 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-19 08:00:592024-07-16 13:59:56Genome editing restores hearing in mice with progressive hearing loss
Professor Nick Macklon

UK study shatters myths on egg freezing success

egg freezing, fertility, pregnancy, reproductive medicine, 18 July 2024/in E-News, Reproduction /by panglobal

A landmark British study spanning 15 years has demonstrated that egg freezing success rates are comparable to routine IVF, offering reassurance to women considering this fertility preservation option.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/Professor-Nick-Macklon.jpg 700 654 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-18 06:10:182024-07-17 08:41:47UK study shatters myths on egg freezing success
fake doctor

Deepfakes of popular TV doctors are being used to sell health scams on social media

AI, deepfake, fraudulent products, scam, The BMJ, 18 July 2024/in AI, E-News /by panglobal

UK television doctors are being impersonated in AI-generated videos to promote fraudulent health products on social media, according to an investigation by The BMJ.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/AI_doctor.png 2944 1632 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-18 01:00:152024-07-16 13:21:55Deepfakes of popular TV doctors are being used to sell health scams on social media
Page 19 of 233«‹1718192021›»

Latest issue of International Hospital

April 2024

11 August 2025

Mayo Clinic unveils breakthrough tool for hidden cancer DNA analysis

8 August 2025

NEFECON receives Chinese approval for expanded IgA nephropathy treatment

7 August 2025

25-year study reveals how SuperAgers defy cognitive decline

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription